B. Kerem

704 total citations
12 papers, 456 citations indexed

About

B. Kerem is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, B. Kerem has authored 12 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in B. Kerem's work include Cystic Fibrosis Research Advances (9 papers), Neonatal Respiratory Health Research (7 papers) and Tracheal and airway disorders (4 papers). B. Kerem is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), Neonatal Respiratory Health Research (7 papers) and Tracheal and airway disorders (4 papers). B. Kerem collaborates with scholars based in Israel, Canada and United States. B. Kerem's co-authors include Robert S. Kass, Jesaia Benhorin, Maya Goldmit, Aharon Medina, Eitan Kerem, Arie Augarten, Naama Rave-Harel, Ran Goshen, Ariel Darvasi and Arye Hurwitz and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The American Journal of Human Genetics.

In The Last Decade

B. Kerem

12 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kerem Israel 9 237 187 145 56 55 12 456
Taro Matsuoka Japan 11 350 1.5× 69 0.4× 135 0.9× 37 0.7× 28 0.5× 24 547
Elke Hobbiebrunken Germany 8 133 0.6× 31 0.2× 35 0.2× 45 0.8× 76 1.4× 11 268
Royston Ong Australia 6 229 1.0× 30 0.2× 127 0.9× 103 1.8× 82 1.5× 10 330
Margaret N. Berry United States 9 182 0.8× 64 0.3× 15 0.1× 15 0.3× 109 2.0× 15 275
Alicia Vaglio United States 7 338 1.4× 38 0.2× 48 0.3× 20 0.4× 159 2.9× 24 548
Janine Smith Australia 8 110 0.5× 30 0.2× 24 0.2× 30 0.5× 42 0.8× 20 253
Justin D. Wagner Canada 7 262 1.1× 20 0.1× 28 0.2× 28 0.5× 68 1.2× 8 461
Melanie Chan United Kingdom 9 96 0.4× 37 0.2× 46 0.3× 18 0.3× 72 1.3× 17 290
S. Constantine United States 9 121 0.5× 201 1.1× 9 0.1× 36 0.6× 29 0.5× 27 477
Maria Accadia Italy 14 136 0.6× 37 0.2× 198 1.4× 4 0.1× 116 2.1× 34 421

Countries citing papers authored by B. Kerem

Since Specialization
Citations

This map shows the geographic impact of B. Kerem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kerem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kerem more than expected).

Fields of papers citing papers by B. Kerem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kerem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kerem. The network helps show where B. Kerem may publish in the future.

Co-authorship network of co-authors of B. Kerem

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kerem. A scholar is included among the top collaborators of B. Kerem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kerem. B. Kerem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Augarten, Arie, Micha Aviram, H. Blau, et al.. (2003). Serum CA 19?9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests. Clinical and Experimental Medicine. 3(2). 119–123. 6 indexed citations
2.
Benhorin, Jesaia, et al.. (2000). Effects of Flecainide in Patients With New SCN5A Mutation. Circulation. 101(14). 1698–1706. 144 indexed citations
3.
Rave-Harel, Naama, Eitan Kerem, Malka Nissim‐Rafinia, et al.. (1997). The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.. PubMed. 60(1). 87–94. 135 indexed citations
4.
Avidor, Boaz, H Zakut, & B. Kerem. (1996). Simple, rapid nonradioactive method to detect major cystic fibrosis mutations in Ashkenazi Jews. Clinical Chemistry. 42(1). 103–105. 5 indexed citations
5.
Augarten, Arie, Eitan Kerem, B. Kerem, et al.. (1995). The significance of sweat Cl/Na ratio in patients with borderline sweat test. Pediatric Pulmonology. 20(6). 369–371. 30 indexed citations
6.
Kerem, B., Naama Rave-Harel, & Ran Goshen. (1994). Genetic evidence for heterogeneity in the etiology of CBAVD: Haplotype analysis in families. The American Journal of Human Genetics. 55. 1 indexed citations
7.
Shoshani, Tzipora, Eitan Kerem, Amir Szeinberg, et al.. (1994). Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.. Journal of Clinical Investigation. 93(4). 1502–1507. 22 indexed citations
8.
Shoshani, Tzipora, Yackov Berkun, Y. Yahav, et al.. (1993). A New Mutation in the CFTR Gene, Composed of Two Adjacent DNA Alterations, Is a Common Cause of Cystic Fibrosis among Georgian Jews. Genomics. 15(1). 236–237. 11 indexed citations
9.
Tsui, L.‐C., Johanna M. Rommens, B. Kerem, et al.. (1991). Molecular Genetics of Cystic Fibrosis. Advances in experimental medicine and biology. 290. 9–18. 18 indexed citations
10.
Rozen, Rima, Robert H. Schwartz, Bettina C. Hilman, et al.. (1990). Cystic fibrosis mutations in North American populations of French ancestry: analysis of Quebec French-Canadian and Louisiana Acadian families.. PubMed. 47(4). 606–10. 22 indexed citations
11.
Rommens, Johanna M., et al.. (1989). Physical localization of two DNA markers closely linked to the cystic fibrosis locus by pulsed-field gel electrophoresis.. PubMed. 45(6). 932–41. 19 indexed citations
12.
Sperling, Karl, et al.. (1985). DNase I sensitivity in facultative and constitutive heterochromatin. Chromosoma. 93(1). 38–42. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026